StockData
TransMedics Group, Inc. logo

TransMedics Group, Inc. (TMDX) stock

TMDXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3028% below fair value
$94.02−2.41 (-2.50%)

Close on Nov 19, 2026Market cap $3.26BP/E 24.4Yield 0.00%

TransMedics free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

TransMedics's free cash flow for the twelve months ending Jun 30, 2026 was $79.04M, up 355.5% year over year. For fiscal 2025 it was $133.59M. The highest annual figure on record is $133.59M in fiscal 2025.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$133.59M–
FY2024Dec 31, 2024-$80.94M–
FY2023Dec 31, 2023-$164.88M–
FY2022Dec 31, 2022-$57.72M–
FY2021Dec 31, 2021-$32.38M–
FY2020Dec 31, 2020-$30.72M–
FY2019Dec 28, 2019-$32.45M–
FY2018Dec 29, 2018-$26.40M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$10.22M-87.6%
Q1 FY2026Mar 31, 2026-$12.12M–
Q4 FY2025Dec 31, 2025$19.00M+213.7%
Q3 FY2025Sep 30, 2025$61.95M–
Q2 FY2025Jun 30, 2025$82.53M+4121.7%
Q1 FY2025Mar 31, 2025-$29.89M–
Q4 FY2024Dec 31, 2024$6.06M–
Q3 FY2024Sep 30, 2024-$41.35M–
Q2 FY2024Jun 30, 2024$1.96M–
Q1 FY2024Mar 31, 2024-$47.61M–
Q4 FY2023Dec 31, 2023-$33.51M–
Q3 FY2023Sep 30, 2023-$114.59M–
Q2 FY2023Jun 30, 2023-$7.18M–
Q1 FY2023Mar 31, 2023-$9.59M–
Q4 FY2022Dec 31, 2022-$6.80M–
Q3 FY2022Sep 30, 2022-$17.21M–
Q2 FY2022Jun 30, 2022-$13.35M–
Q1 FY2022Mar 31, 2022-$20.36M–
Q4 FY2021Dec 31, 2021-$9.83M–
Q3 FY2021Sep 30, 2021-$9.42M–
Q2 FY2021Jun 30, 2021-$5.79M–
Q1 FY2021Mar 31, 2021-$7.35M–
Q4 FY2020Dec 31, 2020-$7.14M–
Q3 FY2020Sep 30, 2020-$6.47M–
Q2 FY2020Jun 30, 2020-$8.66M–
Q1 FY2020Mar 31, 2020-$8.45M–
Q4 FY2019Dec 28, 2019-$7.25M–
Q3 FY2019Sep 28, 2019-$5.63M–
Q2 FY2019Jun 29, 2019-$12.31M–
Q1 FY2019Mar 30, 2019-$7.27M–
Q4 FY2018Dec 29, 2018-$6.25M–
Q3 FY2018Sep 29, 2018-$6.31M–
Q2 FY2018Jun 30, 2018-$7.47M–
Q1 FY2018Mar 31, 2018-$6.37M–

More TransMedics figures

See a number that looks wrong?